Germline KRAS mutations cause Noonan syndrome
- PMID: 16474405
- DOI: 10.1038/ng1748
Germline KRAS mutations cause Noonan syndrome
Erratum in
- Nat Genet. 2006 May;38(5):598
Abstract
Noonan syndrome (MIM 163950) is characterized by short stature, facial dysmorphism and cardiac defects. Heterozygous mutations in PTPN11, which encodes SHP-2, cause approximately 50% of cases of Noonan syndrome. The SHP-2 phosphatase relays signals from activated receptor complexes to downstream effectors, including Ras. We discovered de novo germline KRAS mutations that introduce V14I, T58I or D153V amino acid substitutions in five individuals with Noonan syndrome and a P34R alteration in a individual with cardio-facio-cutaneous syndrome (MIM 115150), which has overlapping features with Noonan syndrome. Recombinant V14I and T58I K-Ras proteins show defective intrinsic GTP hydrolysis and impaired responsiveness to GTPase activating proteins, render primary hematopoietic progenitors hypersensitive to growth factors and deregulate signal transduction in a cell lineage-specific manner. These studies establish germline KRAS mutations as a cause of human disease and infer that the constellation of developmental abnormalities seen in Noonan syndrome spectrum is, in large part, due to hyperactive Ras.
Similar articles
-
Expansion of the genotypic and phenotypic spectrum in patients with KRAS germline mutations.J Med Genet. 2007 Feb;44(2):131-5. doi: 10.1136/jmg.2006.046300. Epub 2006 Oct 20. J Med Genet. 2007. PMID: 17056636 Free PMC article.
-
Germline gain-of-function mutations in SOS1 cause Noonan syndrome.Nat Genet. 2007 Jan;39(1):70-4. doi: 10.1038/ng1926. Epub 2006 Dec 3. Nat Genet. 2007. PMID: 17143285
-
Mutation analysis of the genes involved in the Ras-mitogen-activated protein kinase (MAPK) pathway in Korean patients with Noonan syndrome.Clin Genet. 2007 Aug;72(2):150-5. doi: 10.1111/j.1399-0004.2007.00839.x. Clin Genet. 2007. PMID: 17661820
-
An unexpected new role of mutant Ras: perturbation of human embryonic development.J Mol Med (Berl). 2007 Mar;85(3):227-35. doi: 10.1007/s00109-006-0135-4. Epub 2007 Jan 9. J Mol Med (Berl). 2007. PMID: 17211612 Free PMC article. Review.
-
Deregulated Ras signaling in developmental disorders: new tricks for an old dog.Curr Opin Genet Dev. 2007 Feb;17(1):15-22. doi: 10.1016/j.gde.2006.12.004. Curr Opin Genet Dev. 2007. PMID: 17208427 Review.
Cited by
-
Current management of juvenile myelomonocytic leukemia and the impact of RAS mutations.Paediatr Drugs. 2012 Jun 1;14(3):157-63. doi: 10.2165/11631360-000000000-00000. Paediatr Drugs. 2012. PMID: 22480363 Review.
-
NRAS Mutations in Noonan Syndrome.Mol Syndromol. 2012 Jun;3(1):34-38. doi: 10.1159/000338467. Epub 2012 May 3. Mol Syndromol. 2012. PMID: 22855653 Free PMC article.
-
A cardiac-enriched microRNA, miR-378, blocks cardiac hypertrophy by targeting Ras signaling.J Biol Chem. 2013 Apr 19;288(16):11216-32. doi: 10.1074/jbc.M112.442384. Epub 2013 Feb 27. J Biol Chem. 2013. Retraction in: J Biol Chem. 2017 Mar 24;292(12):5123. doi: 10.1074/jbc.A112.442384. PMID: 23447532 Free PMC article. Retracted.
-
The RASopathies.Annu Rev Genomics Hum Genet. 2013;14:355-69. doi: 10.1146/annurev-genom-091212-153523. Epub 2013 Jul 15. Annu Rev Genomics Hum Genet. 2013. PMID: 23875798 Free PMC article. Review.
-
Structural and mechanistic insights into LEOPARD syndrome-associated SHP2 mutations.J Biol Chem. 2013 Apr 12;288(15):10472-82. doi: 10.1074/jbc.M113.450023. Epub 2013 Mar 1. J Biol Chem. 2013. PMID: 23457302 Free PMC article.
Publication types
MeSH terms
Substances
Associated data
- Actions
- Actions
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Miscellaneous